论文信息 - Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma versus therapy in - 字舞流文

Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma versus therapy in

E. Campo | J. Radford | L. Arcaini | F. Morschhauser | S. Rule | M. Patturajan | W. Jurczak | D. Belada | T. Lamy | J. Mayer | Julia Alexeeva | Jan | M. Bravo | Walewski | Jose Cabeęadas | -. Tsve | tan Biyukov